https://www.thebodypro.com/collection/hepatitis-c

Featured

Investigational Hepatitis C Drugs Show Promising Results Img
Hepatitis C

Investigational Hepatitis C Drugs Show Promising Results

Newer hepatitis C (HCV) drugs have shown very good sustained viral response rates and little risk of resistance-associated substitutions, David L. Wyles, M.D., reported in a webinar.

Addressing Hepatitis C Treatment Barriers Among HCV/HIV-Coinfected Patients Img
Hepatitis C

Addressing Hepatitis C Treatment Barriers Among HCV/HIV-Coinfected Patients

To help clinicians and patients navigate the challenges of HIV/HCV coinfection, AETC NCRC released an infographic that addresses the most common barriers preventing HIV-positive people from curing their HCV infection.

Cochrane Nonsense Review of HCV Treatment Misses Real Issues of Access to Care Img
Hepatitis C

Cochrane Nonsense Review of HCV Treatment Misses Real Issues of Access to Care

A Cochrane review of new hepatitis C drugs has discredited what can be a useful process for combining results from multiple studies, and irresponsible reporting of the review risks limiting access to effective treatment.

New Hepatitis C Infections Nearly Tripled Over Five Years Img
Hepatitis C

New Hepatitis C Infections Nearly Tripled Over Five Years

Over just five years, the number of new hepatitis C virus infections reported to the U.S. CDC has nearly tripled, reaching a 15-year high.

Where Harm Reduction Policies Went Up, Hepatitis C Incidence Went Down, Study Finds Img
Hepatitis C

Where Harm Reduction Policies Went Up, Hepatitis C Incidence Went Down, Study Finds

The first study of hepatitis C incidence and injecting behavior across cities and over 25 years showed the differences in incidence reflect differences in policies to reduce the harm of injecting drug use.

Shame Canada: Canadian Task Force Ignores Expert Advice in New Hepatitis C Screening Guidelines Img
Hepatitis C

Shame Canada: Canadian Task Force Ignores Expert Advice in New Hepatitis C Screening Guidelines

"The new screening guidelines ignore expert advice regarding who should be tested for hep C, setting a dangerous public health policy where dollars come first and the health of Canadians comes last."

Getting in Sync on HIV, Hepatitis C and LGBT Health Img
Hepatitis C

Getting in Sync on HIV, Hepatitis C and LGBT Health

The 2017 Synchronicity Conference, a national conference that focuses on HIV and hepatitis C, also addressed LGBT health for the first time this year.

Kids With Hepatitis C Get New Drugs and Coverage May Prove Easier Than for Adults Img
Hepatitis C

Kids With Hepatitis C Get New Drugs and Coverage May Prove Easier Than for Adults

With the approval this month of two drugs to treat hepatitis C in children, these often overlooked victims of the opioid epidemic have a better chance at a cure.

Most HIV/HCV-Positive Individuals Who Use Drugs Willing to Start HCV Treatment Img
Hepatitis C

Most HIV/HCV-Positive Individuals Who Use Drugs Willing to Start HCV Treatment

Nearly three-quarters of HIV/hepatitis C (HCV)-coinfected drug users reported willingness to use direct-activing antivirals (DAAs) for HCV, a substantial improvement over the willingness of this group to use interferon-based regimens.

How Hepatitis Became a Hidden Epidemic in Africa Img
Hepatitis C

How Hepatitis Became a Hidden Epidemic in Africa

"This epidemic is even more worrying when we consider how hard it is to get treated -- only 1% of chronic carriers can access treatment."